DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trilipix (Choline Fenofibrate) - Current Clinical Trials


Trilipix Related Clinical Trials

Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension [Completed]

Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL) [Terminated]

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease [Completed]

Bioequivalence Study of Fenofibric Acid Versus TricorŽ (Fenofibrate) [Completed]

A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic [Completed]

Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone [Recruiting]

Fed Bioequivalence Study of Fenofibric Acid Versus TriCorŽ (Fenofibrate) [Completed]

Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin [Recruiting]

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma [Recruiting]

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or LovazaŽ in Patients With Severe Hypertriglyceridemia [Completed]

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans [Completed]

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia [Completed]

Fenofibrate Bioequivalence Study (0767-031) [Completed]

Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia [Completed]

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels [Completed]

Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia [Active, not recruiting]

Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment [Completed]

Effect of Fenofibrate on Sleep Apnea Syndrome [Terminated]

Evaluate the Efficacy of Fenofibrate on Microalbuminuria [Not yet recruiting]

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients [Recruiting]

Predictors of Response to Fenofibrate [Completed]

Fenofibrate and Propranolol in Burn Patients [Not yet recruiting]

A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia [Completed]

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease [Completed]

Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome [Recruiting]

A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume [Not yet recruiting]

Use of Fenofibrate for Primary Biliary Cirrhosis [Completed]

Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy [Completed]

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study [Active, not recruiting]

Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate [Withdrawn]

LXRA Gene Polymorphisms and Response to Fenofibrate [Terminated]

Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia [Not yet recruiting]

Fenofibrate Treatment in SCI [Active, not recruiting]

A Study to Evaluate the Efficacy and Safety of Pravastatin/Fenofibrate Complex in Patients With Combined Dyslipidemia With Adequately Controlled LDL-C But Inadequately Controlled Triglyceride Level by Atorvastatin Monotherapy [Recruiting]

Effects of Fenofibrate on Gene Expression in Healthy Volunteers [Completed]

Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin [Completed]

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia [Recruiting]

Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Completed]

Fenofibrate for PSC [Terminated]

Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions [Completed]

Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes [Recruiting]

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions [Completed]

Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions [Completed]

Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-Lowering Strategy [Completed]

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes [Completed]

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis [Withdrawn]

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome. [Completed]

Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome [Terminated]

Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients [Recruiting]

A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome [Available]

Treatment of Hyperlipidemia and Sexual Dysfunction [Active, not recruiting]

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin [Recruiting]

Effect of Alirocumab SAR236553 (REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects [Completed]

Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Completed]

Relative Bioavailability Study of LipidilŽ Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg) [Completed]

Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin [Completed]

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [Completed]

A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. [Not yet recruiting]

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia [Completed]

ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study [Completed]

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate [Completed]

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions [Completed]

Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study [Terminated]

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia [Completed]

Effect of a Fibrate and a Statin on Endothelial Dysfunction [Terminated]

Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate [Completed]

Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis [Completed]

A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome [Completed]

Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People [Completed]

Insulin Resistance in Non-alcoholic Fatty Liver Disease [Terminated]

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids [Completed]

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia [Completed]

Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome [Completed]

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol [Completed]

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer [Completed]

Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation [Active, not recruiting]

Pharmacological Regulation of Fat Transport in Metabolic Syndrome [Completed]

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate [Completed]

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin [Completed]

High-Density Lipoprotein (HDL) Treatment Study [Completed]

Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) [Completed]

Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function [Active, not recruiting]

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016) [Terminated]

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. [Terminated]

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood [Completed]

Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents [Completed]

Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED) [Completed]

Interaction Between ABT-335, Rosuvastatin and Warfarin [Completed]

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood [Completed]

Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) [Completed]

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. [Completed]

CKD-337(2) Drug-drug Interaction Study [Recruiting]

A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz [Completed]

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules [Completed]

Manipulation Under Anesthesia Versus Arthroscopic Capsular Release in the Treatment of Adhesive Capsulitis [Recruiting]

A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet [Completed]

A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017